Moscow, Russia

Dimitri A Karkevich

This inventor holds 1 USPTO granted patent. Top assignee: Medinova Medical Consulting Gmbh. Active years: 2000.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 64(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Dimitri A Karkevich

Introduction

Dimitri A Karkevich is a notable inventor based in Moscow, Russia. He has made significant contributions to the field of drug delivery systems, particularly in targeting the nervous system. His innovative approach has the potential to revolutionize how therapeutic agents are administered to patients.

Latest Patents

Dimitri holds a patent for a groundbreaking method titled "Drug targeting to the nervous system by nanoparticles." This patent describes a novel technique for delivering drugs and diagnostics across the blood-brain barrier or blood-nerve barrier. The method involves incorporating drugs or diagnostic agents into nanoparticles, which are then coated with additional surfactants and administered to animals or humans. This innovative approach allows for several benefits, including reducing the required dose of therapeutic drugs, enabling drugs that typically do not cross the blood-brain barrier to penetrate the nervous system, and minimizing peripheral side effects by increasing the amount of the drug that reaches the brain. He has 1 patent to his name.

Career Highlights

Dimitri A Karkevich is currently associated with Medinova Medical Consulting GmbH, where he continues to work on advancing medical technologies. His expertise in nanoparticle technology and drug delivery systems has positioned him as a key figure in the field.

Collaborations

Dimitri has collaborated with notable professionals in his field, including Renad N Alyautdin and Jorg Kreuter. These collaborations have further enhanced his research and development efforts in drug delivery systems.

Conclusion

Dimitri A Karkevich's innovative work in drug targeting through nanoparticles represents a significant advancement in medical science. His contributions have the potential to improve therapeutic outcomes for patients with neurological conditions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…